CPEB1
Basic information
Region (hg38): 15:82543201-82648861
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CPEB1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 27 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 28 | 0 | 1 |
Variants in CPEB1
This is a list of pathogenic ClinVar variants found in the CPEB1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-82546483-A-C | not specified | Uncertain significance (Sep 16, 2021) | ||
15-82547216-T-C | not specified | Uncertain significance (Feb 27, 2024) | ||
15-82549585-C-T | not specified | Uncertain significance (Jan 04, 2024) | ||
15-82549604-G-C | not specified | Uncertain significance (Feb 15, 2023) | ||
15-82552547-G-A | not specified | Uncertain significance (Jul 25, 2023) | ||
15-82552566-G-C | not specified | Uncertain significance (Apr 17, 2023) | ||
15-82553517-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
15-82553542-T-C | not specified | Uncertain significance (Jul 19, 2022) | ||
15-82553887-T-C | not specified | Uncertain significance (Jun 10, 2024) | ||
15-82553914-C-T | not specified | Uncertain significance (Oct 05, 2022) | ||
15-82553963-A-C | not specified | Uncertain significance (Jun 22, 2023) | ||
15-82555946-T-C | Benign (Dec 31, 2019) | |||
15-82556029-C-T | not specified | Uncertain significance (Sep 21, 2021) | ||
15-82556112-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
15-82557840-G-C | not specified | Uncertain significance (Dec 07, 2021) | ||
15-82557848-C-T | not specified | Uncertain significance (Jan 26, 2022) | ||
15-82557849-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
15-82557861-G-A | not specified | Uncertain significance (Nov 22, 2023) | ||
15-82557960-C-T | not specified | Uncertain significance (Sep 22, 2022) | ||
15-82557975-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
15-82571346-G-A | not specified | Uncertain significance (Jun 22, 2023) | ||
15-82571385-G-A | not specified | Uncertain significance (Jan 06, 2023) | ||
15-82571398-G-C | not specified | Uncertain significance (Jun 17, 2024) | ||
15-82571478-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
15-82571484-G-A | not specified | Uncertain significance (Nov 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CPEB1 | protein_coding | protein_coding | ENST00000568128 | 12 | 105662 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.00101 | 124449 | 0 | 5 | 124454 | 0.0000201 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.10 | 194 | 296 | 0.656 | 0.0000159 | 3655 |
Missense in Polyphen | 45 | 114.48 | 0.39307 | 1442 | ||
Synonymous | -0.325 | 114 | 110 | 1.04 | 0.00000564 | 1129 |
Loss of Function | 4.63 | 2 | 28.8 | 0.0694 | 0.00000181 | 309 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000132 | 0.000129 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000416 | 0.0000329 |
Other | 0.000408 | 0.000331 |
dbNSFP
Source:
- Function
- FUNCTION: Sequence-specific RNA-binding protein that regulates mRNA cytoplasmic polyadenylation and translation initiation during oocyte maturation, early development and at postsynapse sites of neurons. Binds to the cytoplasmic polyadenylation element (CPE), an uridine-rich sequence element (consensus sequence 5'-UUUUUAU- 3') within the mRNA 3'-UTR. RNA binding results in a clear conformational change analogous to the Venus fly trap mechanism (PubMed:24990967). In absence of phosphorylation and in association with TACC3 is also involved as a repressor of translation of CPE-containing mRNA; a repression that is relieved by phosphorylation or degradation (By similarity). Involved in the transport of CPE-containing mRNA to dendrites; those mRNAs may be transported to dendrites in a translationally dormant form and translationally activated at synapses (By similarity). Its interaction with APLP1 promotes local CPE-containing mRNA polyadenylation and translation activation (By similarity). Induces the assembly of stress granules in the absence of stress. Required for cell cycle progression, specifically for prophase entry (PubMed:26398195). {ECO:0000250|UniProtKB:P70166, ECO:0000269|PubMed:15731006, ECO:0000269|PubMed:15966895, ECO:0000269|PubMed:24990967, ECO:0000269|PubMed:26398195}.;
- Pathway
- Oocyte meiosis - Homo sapiens (human);Progesterone-mediated oocyte maturation - Homo sapiens (human);Aurora A signaling
(Consensus)
Recessive Scores
- pRec
- 0.104
Intolerance Scores
- loftool
- 0.0281
- rvis_EVS
- -0.56
- rvis_percentile_EVS
- 19.73
Haploinsufficiency Scores
- pHI
- 0.405
- hipred
- N
- hipred_score
- 0.492
- ghis
- 0.556
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.524
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cpeb1
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); reproductive system phenotype; cellular phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- mRNA processing;translation;cellular response to insulin stimulus;cellular response to amino acid stimulus;cellular response to hypoxia;positive regulation of mRNA polyadenylation;negative regulation of cytoplasmic translation
- Cellular component
- P-body;nucleus;nucleoplasm;cytoplasm;cytosol;postsynaptic density;cell junction;dendrite;neuron projection;synapse;postsynaptic membrane;messenger ribonucleoprotein complex
- Molecular function
- translation repressor activity, mRNA regulatory element binding;mRNA 3'-UTR binding;protein binding;translation factor activity, RNA binding;mRNA 3'-UTR AU-rich region binding;ribosome binding;metal ion binding